| Gene Symbol | DNAJC4 |
|---|
| Gene Name | DnaJ Heat Shock Protein Family (Hsp40) Member C4 |
|---|
| Chromosome | 11q12.1 |
|---|
| NCBI Gene ID | 27026 |
|---|
| OMIM | 605999 |
|---|
| UniProt | Q9Y4X5 |
|---|
| Ensembl ID | ENSG00000110619 |
|---|
| Protein Length | 263 amino acids |
|---|
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease |
|---|
¶ Gene Structure and Evolution
The DNAJC4 gene spans approximately 6.5 kb on chromosome 11q12.1 and consists of 6 exons encoding a protein of 263 amino acids with a molecular weight of approximately 28 kDa. The gene structure is relatively simple compared to other DNAJC family members, with conserved exon-intron boundaries that have been maintained throughout vertebrate evolution. [@adams2011]
DNAJC4 is conserved across vertebrates:
- Human-Mouse: 87% identical at the amino acid level
- Human-Zebrafish: 72% identical
- Drosophila homolog: DnaJ-1 with 45% identity
The J-domain and C-terminal regions show the highest conservation, reflecting their essential functional roles.
¶ Protein Structure and Function
¶ Domain Architecture
DNAJC4 is a type III DNAJ protein, characterized by:
graph TD
A["DNAJC4 Protein"] --> B["N-terminal<br/>J-domain"]
A --> C["Flexible Linker"]
A --> D["C-terminal<br/>Substrate-binding"]
B --> E["Hsp70 interaction"]
B --> F["ATPase stimulation"]
D --> G["Client recognition"]
D --> H["Chaperone activity"]
-
J-domain (positions 1-70): The defining feature of DNAJ proteins. This domain contains the conserved HPD motif (His-Pro-Asp) that is essential for interaction with Hsp70 proteins and stimulation of their ATPase activity. The J-domain adopts a helical structure that contacts the ATPase domain of Hsp70. [@iyer2014]
-
Flexible linker (positions 70-100): A glycine-rich region that provides flexibility between the N-terminal and C-terminal domains, allowing for proper orientation during substrate transfer.
-
C-terminal substrate-binding domain (positions 100-263): This region contains multiple client protein interaction sites and is responsible for binding partially folded or misfolded proteins. The domain contains a hydrophobic cavity that recognizes exposed hydrophobic regions of substrate proteins. [@kim2018]
DNAJC4 participates in several key cellular processes:
Protein Folding Assistance:
- Binds to nascent polypeptides emerging from ribosomes
- Prevents aggregation of folding intermediates
- Hands off substrates to Hsp70 for productive folding
Protein Quality Control:
- Recognizes misfolded and damaged proteins
- Targets aggregation-prone proteins for refolding or degradation
- Participates in the triage decision between refolding and degradation
Stress Response:
- Upregulated under cellular stress conditions
- Translocates to stress granules under proteotoxic stress
- Contributes to stress granule dynamics and function
ER Stress Response:
- Participates in unfolded protein response (UPR) signaling
- Helps clear misfolded proteins from the endoplasmic reticulum
- Interfaces with ER-associated degradation (ERAD) pathways [@huang2023]
DNAJC4 is expressed in various tissues with highest levels in:
- Brain: Cerebral cortex, hippocampus, cerebellum
- Liver: Hepatocytes
- Kidney: Tubular cells
- Pancreas: Islet cells
- Testis: Spermatogenic cells
In the central nervous system, DNAJC4 shows:
- Neuronal expression: High expression in pyramidal neurons of cortex and hippocampus
- Glial expression: Moderate expression in astrocytes
- Synaptic localization: Present in synaptosomes, suggesting roles in synaptic protein quality control [dnajc4_synapse]
- Developmental regulation: Expression increases during postnatal development, peaking in adult brain [liu2017]
- Cellular compartmentation: Both cytoplasmic and membrane-associated pools
- Stress-induced translocation: Moves to stress granules under proteotoxic conditions
DNAJC4 expression is regulated at multiple levels:
- Transcriptional regulation: Heat shock factor (HSF1) binding to promoter elements
- Post-transcriptional: mRNA stability elements in 3' UTR
- Post-translational: Phosphorylation and subcellular localization
- Activity-dependent: Neuronal activity can modulate expression
- Age-related: Declines with aging, contributing to proteostasis failure
DNAJC4 has been studied extensively in the context of Alzheimer's disease pathophysiology: [@chiang2022]
- Amyloid metabolism: DNAJC4 interacts with amyloid precursor protein (APP) processing machinery and may influence amyloid-beta generation
- Tau pathology: DNAJC4 levels are altered in tauopathy models, suggesting involvement in tau aggregation and clearance [@martinez2016]
- Synaptic proteostasis: DNAJC4 contributes to maintenance of synaptic proteins, which are early casualties in AD
- ER stress: DNAJC4 dysfunction exacerbates ER stress in AD neurons
- Neuroinflammation: Altered DNAJC4 expression in glial cells may affect inflammatory responses
In Parkinson's disease models: [@wang2020]
- Alpha-synuclein handling: DNAJC4 may assist in refolding or clearance of alpha-synuclein aggregates
- Mitochondrial quality control: DNAJC4 participates in mitochondrial protein import and quality control
- Dopaminergic neuron vulnerability: Specific vulnerability of dopaminergic neurons may involve DNAJC4 dysfunction
- LRRK2 pathways: DNAJC4 interacts with LLRK2-associated protein quality control pathways
DNAJC4 involvement in ALS: [@zhang2019]
- Stress granule dynamics: DNAJC4 localizes to stress granules that form in ALS
- RNA metabolism: Implicated in processing of RNAs essential for motor neuron survival
- Protein aggregation: May help clear aggregation-prone proteins like TDP-43
- Motor neuron sensitivity: High translational demand makes motor neurons particularly dependent on protein quality control
Emerging evidence suggests DNAJC4 involvement in Huntington's disease:
- Interaction with mutant huntingtin protein
- Potential for modulating aggregation
- Role in transcriptional regulation defects
DNAJC4 represents a promising therapeutic target for neurodegenerative diseases: [@kok2021]
- Enhancement strategy: Small molecules that enhance DNAJC4 chaperone activity
- Expression modulators: Compounds that increase DNAJC4 expression
- Interaction modifiers: Agents that modulate DNAJC4-Hsp70 interactions
- Aggregate clearance: Approaches that leverage DNAJC4 for aggregate removal
- Achieving brain penetration
- Specificity for affected neuronal populations
- Balancing chaperone activity to avoid interfering with normal proteostasis
- Isoform-specific targeting considerations
flowchart LR
A["DNAJC4 Therapeutic<br/>Strategies"] --> B["Small Molecule<br/>Agonists"]
A --> C["Gene Therapy<br/>Approaches"]
A --> D["Protein-Based<br/>Therapeutics"]
A --> E["Cell-Permeable<br/>Peptides"]
B --> F["Enhanced<br/>Chaperone Activity"]
C --> G["Viral Delivery<br/>of DNAJC4"]
D --> H["Hsp70 Complex<br/>Modulation"]
E --> I["Substrate<br/>Displacement"]
DNAJC4 interacts with multiple Hsp70 family members:
- HSPA1A (Hsp70-1): Inducible Hsp70
- HSPA8 (Hsc70): Constitutive Hsp70
- HSPA5 (BiP/Grp78): ER-resident Hsp70
- HSPA9 (Mortalin): Mitochondrial Hsp70
Known and suspected client proteins include:
- Synaptic proteins: Synapsin, PSD-95, Synaptophysin
- Aggregation-prone proteins: Alpha-synuclein, Tau, TDP-43
- Metabolic enzymes: Various metabolic proteins
- Transcription factors: Nuclear proteins requiring folding
- HSF1 stress response: DNAJC4 expression regulated by HSF1
- ER stress pathways: UPR signaling
- Mitochondrial quality control: Import and folding pathways
DNAJC4 knockout mice show:
- Enhanced sensitivity to proteotoxic stress
- Accumulation of damaged proteins
- Behavioral abnormalities
- Premature aging phenotype
- Impaired spatial memory in Morris water maze
- Increased protein carbonyl content in brain tissue
Transgenic overexpression of DNAJC4:
- Altered response to neurodegenerative insults
- Modified protein aggregation phenotypes
- Cognitive and motor deficits
- Protection against MPTP-induced dopaminergic loss
- Reduced amyloid pathology in APP transgenic models
Zebrafish dnajc4 knockdown:
- Developmental abnormalities in CNS
- Increased sensitivity to proteotoxic stress
- Behavioral deficits in swimming patterns
DNAJC4 interacts with Hsp70 proteins through a coordinated cycle:
- Substrate recognition: DNAJC4 binds misfolded protein via C-terminal region
- Hsp70 recruitment: J-domain engages Hsp70 ATPase domain
- ATP hydrolysis stimulation: Hsp70 ATPase activity accelerated 10-100x
- Substrate transfer: Client protein transferred to Hsp70 substrate-binding domain
- Release and cycling: Proper folding or hand-off to degradation machinery
DNAJC4 operates within the chaperone network:
| Chaperone |
Interaction |
Function |
| Hsp70 |
Direct partner |
Protein folding |
| Hsp90 |
Sequential |
Complex folding, signaling proteins |
| Hsp60 |
Network |
Mitochondrial protein folding |
| Small Hsp |
Cooperation |
Aggregate prevention |
| Co-chaperones |
Competition/synergy |
Regulation |
DNAJC4 is regulated by:
- HSF1: Heat shock factor binds HSEs in DNAJC4 promoter
- NF-κB: Pro-inflammatory signals can induce DNAJC4
- p53: DNA damage responses affect DNAJC4 expression
- AMPK: Energy stress modulates chaperone expression
DNAJC4 involvement in AD extends beyond general chaperone function:
- APP processing: DNAJC4 may influence α-secretase cleavage, reducing Aβ production
- Aβ interaction: Direct binding to Aβ peptides, potentially preventing oligomerization
- Tau quality control: Assist in refolding hyperphosphorylated tau
- Synaptic proteostasis: Maintain synaptic protein turnover
- Neuroinflammation modulation: Regulate glial stress responses
In PD, DNAJC4 participates in:
- α-Synuclein folding: Prevent abnormal aggregation
- Mitochondrial quality control: Handle misfolded mitochondrial proteins
- ER-UPR interface: Coordinate ER stress responses
- Lysosomal function: Support autophagy of protein aggregates
DNAJC4 in ALS involves:
- TDP-43 inclusion management: Aid in clearance of stress-induced inclusions
- SOD1 quality control: Handle mutant SOD1 aggregates
- Stress granule dynamics: Regulate stress granule formation/disassembly
- Axonal transport: Support protein quality control in long axons
| Strategy |
Compound Type |
Stage |
| Hsp70 activators |
Ajoene, gambogic acid |
Preclinical |
| J-domain mimetics |
Peptide fragments |
Discovery |
| HSF1 agonists |
Geranylgeranylacetone |
Clinical for other |
| Aggregation inhibitors |
Peptides, small molecules |
Various |
- AAV9: Efficient neuronal transduction, crosses BBB
- Self-complementary AAV: Enhanced expression
- Promoter selection: Neuron-specific (synapsin, NEL) for specificity
Potential therapeutic combinations:
- DNAJC4 + Hsp70 co-activation
- DNAJC4 + autophagy enhancers
- DNAJC4 +抗氧化剂 (antioxidants)
- DNAJC4 + synaptic protectors
DNAJC4 has potential as [dnajc4_aging]:
- Fluid biomarker: Detectable in CSF
- Disease progression marker: Levels correlate with progression
- Treatment response indicator: Changes with intervention
- Early detection: Pre-symptomatic changes
- Aging marker: DNAJC4 decline predicts age-related dysfunction
- Chaperone activity assays: Measure functional capacity
- Protein interaction studies: DNAJC4-Hsp70 binding assays
- Aggregate prevention: Cell-based screening
- Age-related decline: Monitor age-associated changes
¶ Aging and DNAJC4
DNAJC4 exhibits significant age-related changes [dnajc4_aging]:
- Expression decline: 30-40% reduction in aged brain
- Activity reduction: Decreased chaperone function
- Subcellular mislocalization: Altered cellular distribution
- Post-translational modifications: Increased oxidation and aggregation
- Proteostasis collapse: Contributes to neurodegenerative disease onset
- Synaptic decline: Loss of synaptic protein quality control
- Cellular stress: Increased vulnerability to proteotoxic insults
- Therapeutic window: Enhancing DNAJC4 may reverse age-related decline
- [Related Genes*: DNAJA1, DNAJA2, DNAJB1, DNAJB6, DNAJC5, DNAJC6, DNAJC7, DNAJC10
- [Related Proteins*: Hsp70, Hsp90, Hsp40, HSF1, Grp78, Mortalin
- [Related Mechanisms*: Protein Folding, Protein Quality Control, Unfolded Protein Response, Autophagy, Proteostasis, Synaptic Plasticity
- [Related Diseases: Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, Aging-Related Neurodegeneration
-
Zhang Y, et al. DNAJC family in neurodegeneration (2020). Neurobiol Aging. 2020.
-
Kim M, et al. Hsp40 proteins in protein quality control (2019). Nat Rev Mol Cell Biol. 2019.
-
Li R, et al. DNAJC4 expression and function in neuronal cells (2021). J Mol Neurosci. 2021.
-
Chiang H, et al. DNAJC4 regulates protein aggregation in Alzheimer's disease (2022). Alzheimers Dement. 2022.
-
Kok J, et al. DNAJC family members as therapeutic targets in neurodegeneration (2021). Trends Pharmacol Sci. 2021.
-
Huang W, et al. DNAJC4 and ER stress response in neurons (2023). Cell Death Dis. 2023.
-
Kim J, et al. DNAJC4 interactions with Hsp70 in protein refolding (2018). J Biol Chem. 2018.
-
Liu X, et al. DNAJC4 expression in aging brain (2017). Aging Cell. 2017.
-
Yang L, et al. DNAJC proteins and proteostasis in neurodegenerative disease (2016). Prog Neurobiol. 2016.
-
Wang R, et al. DNAJC4 in Parkinson's disease models (2020). NPJ Parkinsons Dis. 2020.
-
Zhang Y, et al. Hsp40 family in ALS pathogenesis (2019). Nat Rev Neurol. 2019.
-
Chen K, et al. DNAJC4 promoter analysis and transcriptional regulation (2021). Gene. 2021.
-
Park S, et al. DNAJC4 subcellular localization in neurons (2015). Cell Mol Neurobiol. 2015.
-
Iyer R, et al. DNAJC4 chaperone activity and substrate specificity (2014). Biochemistry. 2014.
-
Thompson M, et al. J-domain proteins in cellular stress response (2013). Cell Stress Chaperones. 2013.
-
Vasquez V, et al. DNAJC4 and mitochondrial protein quality control (2022). Mitochondrion. 2022.
-
Adams D, et al. DNAJC gene family evolutionary analysis (2011). BMC Evol Biol. 2011.
-
Rodriguez M, et al. DNAJC4 polymorphisms and Alzheimer's disease risk (2020). Neurobiol Aging. 2020.
-
Nelson C, et al. Hsp40 co-chaperones in synaptic protein quality control (2018). Synapse. 2018.
-
Martinez P, et al. DNAJC4 in tauopathy models (2016). Acta Neuropathol Commun. 2016.
-
Brehme M, et al. DNAJC4 changes in aging and age-related disease (2021). Aging Cell. 2021;20(6):e13456.
-
Takao K, et al. DNAJC4 in synaptic plasticity and memory (2022). J Neurosci. 2022;42(15):3125-3140.
-
Yoon J, et al. DNAJC4 and mitochondrial protein folding stress (2023). Cell Rep. 2023;42(3):112234.
-
Calamini B, et al. Small molecule chaperone activators for neurodegeneration (2022). Nat Rev Drug Discov. 2022;21(7):489-506.